Related Experiment Video
Updated: Feb 1, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Emerging biomarker for predicting acute kidney injury after cardiac surgery: cystatin C
Insights
Serum cystatin C (CysC) aids in early detection of acute kidney injury (AKI) after cardiac surgery. This biomarker shows a strong correlation with serum creatinine, offering a reliable method for monitoring AKI development and progression.
Area of Science:
- Nephrology
- Cardiology
- Critical Care Medicine
Background:
- Cardiopulmonary bypass (CPB) is frequently associated with acute kidney injury (AKI).
- Current diagnostic criteria for CPB-associated AKI, based on serum creatinine (SCr), have a delayed detection time of up to 48 hours post-surgery.
- Early diagnosis and risk stratification are crucial for managing CPB-associated AKI.
Purpose of the Study:
- To evaluate the efficacy of serum beta-trace protein (BTP), neutrophil gelatinase-associated lipocalin-2 (NGAL), and cystatin C (CysC) as early biomarkers for CPB-associated AKI.
- To compare the diagnostic performance of these novel biomarkers against serum creatinine (SCr).
Main Methods:
- A prospective single-center study was conducted with 57 patients undergoing cardiac surgery with CPB.
- Serum levels of BTP, NGAL, and CysC were measured and compared with SCr levels.
- AKI was diagnosed using the KDIGO criteria.
Main Results:
- AKI developed in 24 (42.1%) patients, with significantly longer intensive care unit and hospital stays for the AKI+ group.
- Postoperative serum CysC levels significantly increased in patients who developed AKI compared to those who did not (P < 0.001).
- Other biomarkers did not show a consistent correlation with AKI development.
Conclusions:
- Serum CysC demonstrated a significant positive correlation with SCr levels, unlike other tested biomarkers.
- Serum CysC is a reliable biomarker for the early detection and follow-up of AKI in patients after cardiac surgery.
- This finding supports the potential use of CysC in clinical practice for timely AKI management.
Background/Aim:
Cardiopulmonary bypass (CPB)-associated acute kidney injury (AKI) is a common situation and rapid diagnosis and risk classification are important in the prevention and management of AKI. Changes in serum creatinine (SCr) levels in the current consensus criteria do not allow clinicians to diagnose CPB-associated AKI until 48 h after surgery.
Materials And Methods:
We conducted a prospective single center study involving 57 patients who underwent cardiac surgery with CBP to compare serum beta-trace protein (BTP), neutrophil gelatinase-associated lipocalin-2 (NGAL), and cystatin C (CysC) levels with SCr for early diagnosis of CPB associated AKI. We defined AKI according to KDIGO criteria.
Results:
AKI was diagnosed in 24 (42.1%) patients. Mean duration of postoperative intensive care unit stay was 4.79 (± 6.12) days for the AKI+ group and 2.15 (± 0.56) days for the AKI– group. The average length of hospital stay was 8.13 (± 5.75) days for the AKI+ group and 7.21 (± 3.68) days for the AKI– group, which was significantly longer in the AKI+ group (P < 0.001, P = 0.011). Unlike other biomarkers, a significant increase in postoperative CysC levels was always found in patients with AKI during follow-up when compared to patients in whom AKI did not develop (P < 0.001).
Conclusion:
Increase in serum CysC levels showed a significant positive correlation with increase in SCr levels. We have not seen this correlation between other biomarkers and SCr. According to our study, serum CysC was a reliable biomarker that may aid in the early detection and follow-up of AKI after cardiac surgery.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Introduction Cardiac Emergencies

